Study: Extending Clinical Data Access Could Raise Drug Costs, Life Expectancy Extending the term of exclusive access to clinical trial data will raise drug costs in the short term but also help ...
MRO announces the acquisition of Clinetic, a leading recruitment management platform designed to help healthcare ...
Medidata has supported the NCI Cancer Therapy Evaluation Program (CTEP) study portfolio with tools across the Medidata Platform for the past 17 years, strengthening the collaboration and reinforcing ...
Foundation Fighting Blindness has granted public access to de-identified 4-year data from individuals participating in RUSH2A ...
Hospital Authority Hong Kong and the Hong Kong Science and Technology Parks Corporation will be co-launching a data collaboration lab to provide access to a sizeable clinical database for non-academic ...
A recent influx of digital technology has unlocked tremendous potential for clinical trials. For an industry that has traditionally relied on patients’ paper intake forms and manual data entry into ...
As biotechs scale up, streamlining the planning, execution, and monitoring of outsourced clinical trials becomes critical. While CROs manage the day-to-day operations, sponsors are ultimately ...
Revolutionary AI assistant RISA eliminates the pain of hunting for patient data across multiple systems, enabling clinicians to focus more on patient care ThetaRho.ai, a provider of AI-powered ...
NEW YORK, Dec 4 (Reuters) - Global drugmaker Pfizer Inc will broaden access to information from its scores of clinical trials to independent researchers and to patients who take part in the studies, ...
A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease Strategies to bring clinical trials closer to patients gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback